Overview A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628 Status: NOT_YET_RECRUITING Trial end date: 2025-06-30 Target enrollment: Participant gender: Summary A phase I clinical trial to evaluate the relative bioavailability of PRAX-628 tablet formulation compared to capsule formulationPhase: PHASE1 Details Lead Sponsor: Praxis Precision Medicines